Evolent Health Depreciation And Amortization Over Time
| EVH Stock | USD 23.08 0.23 0.99% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Evolent Health Performance and Evolent Health Correlation. Evolent |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 19.283 | Quarterly Revenue Growth 0.496 | Return On Assets 0.0062 | Return On Equity (0.09) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Depreciation And Amortization Analysis
Compare Evolent Health and related stocks such as Progyny, Teladoc, and 10X Genomics Depreciation And Amortization Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGNY | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.9 M | 2.1 M | 1.9 M | 1.3 M | 1.6 M | 2.3 M | 2 M |
| TDOC | 754 K | 754 K | 754 K | 754 K | 2.3 M | 4.9 M | 8.3 M | 19.1 M | 35.6 M | 45 M | 78.1 M | 224.7 M | 270.6 M | 351.3 M | 368.9 M |
| TXG | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 3.9 M | 2.6 M | 2.9 M | (596 K) | 6.4 M | 43.6 M | 45.8 M |
| SDGR | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 2.9 M | (6.3 M) | (24.6 M) | (8.5 M) | 4.3 M | 5.6 M | 5.8 M |
| GEHC | 714 M | 714 M | 714 M | 714 M | 714 M | 714 M | 714 M | 714 M | 714 M | 714 M | 686 M | 745 M | 700 M | 610 M | 552.8 M |
Evolent Health and related stocks such as Progyny, Teladoc, and 10X Genomics Depreciation And Amortization description
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.My Equities
My Current Equities and Potential Positions
| Evolent Health | EVH |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Virginia; U.S.A |
| Exchange | New York Stock Exchange |
USD 23.08
Check out Evolent Health Performance and Evolent Health Correlation. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Evolent Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.